A first-time UK research order is often treated less like a routine catalogue purchase and more like a compliance and documentation check. When the request is for a fixed peptide blend—two or more peptides supplied in one vial at a set ratio—the supplier has to answer questions that do not arise for a single catalogue item. The issue is rarely a simple “no” to research supply. It is usually about whether the requested format can be lawfully supplied, documented, characterised and handled within an in-vitro laboratory workflow. All research materials discussed here are strictly for controlled laboratory and analytical research; they are not for human or veterinary use, consumption, administration or clinical application.
Compliance Screening Makes a Non-Standard Request Stand Out
A first-time order carries no previous transaction history, so a supplier has less context for the intended research use. That does not mean first-time buyers are treated as suspect by default, but it does mean a non-standard request can attract additional scrutiny. Research-use-only materials are not medicines, medical devices, injectables, treatments or food supplements under UK law. The supplier’s stated position is that products are labelled “For Research Use Only – Not for Human Consumption”, in line with MHRA guidance as the shop describes it. A request that uses therapeutic, clinical, dosing or administration language can therefore be refused before any stock or dispatch question is considered.
A fixed blend can create a compliance signal because it looks like a custom combination rather than a catalogue item. Research Sciences states that it does not supply blended peptides, such as Ipamorelin + CJC-1295, and recommends buying peptides individually and combining only within a controlled experimental design. On that basis, a refusal may be a straightforward catalogue-policy decision: the supplier does not offer blended vials, and a first-time order does not change that position. The purchaser remains responsible for lawful use, safe handling, storage and disposal, and for compliance with relevant UK regulations including COSHH and laboratory safety standards.
The practical lesson is to separate research intent from commercial convenience. A laboratory may prefer one vial at a fixed ratio, but a supplier may only be able to release individual catalogue items with matching batch documentation. A first-time buyer should describe the in-vitro context clearly, avoid clinical or dosing language, and check whether the requested presentation exists in the catalogue at all. If it does not, refusal is not necessarily a judgement on the research project; it may simply be the supplier declining to create a non-standard format outside its documented supply model.
Documentation, Identity and Batch Traceability
A single catalogue item can usually be linked to a specific batch record and a Certificate of Analysis. A fixed blend is harder to document because the supplier must show what was tested, which sample the certificate refers to, and how the batch is identified after release. Research Sciences describes batch-level analytical verification supporting purity, identity and contaminant screening, with CoAs linked to supported products. If a blended vial is not a supported catalogue line, the supplier may have no matching CoA structure for it. That is a documentation problem before it is a logistics problem.
The shop’s published testing framework refers to purity, identity, heavy metals and endotoxin evaluation of submitted samples, and the homepage lists “CoAs Janoshik Analytical Reports”. Those statements should be read as the shop’s current published wording and reconfirmed against the live site and the batch CoA. For a fixed blend, a researcher should not assume that separate certificates for two peptides can simply be averaged or attached to one blended vial. The supplier may refuse because it cannot map the requested presentation to a batch document that a laboratory can verify. The site’s published ≥99% purity headline should likewise be treated as a summary; the exact purity and identity details should be checked on the CoA for the specific batch.
Traceability matters in a first-time order because the buyer has no established record with the supplier. Vial labels use a reference format combining SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. Researchers should quote that reference when asking about documentation. The FAQs also note that restocked products may carry the same Internal Test Reference as earlier stock; an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. A blended request can complicate that chain further, so a supplier may prefer to supply individual vials that already have a clear documentation route. The Peptides uk catalogue is organised around individual catalogue items with batch documentation, not bespoke fixed-ratio combinations.
In-Vitro Handling, Storage and Experimental Design
Handling and storage also explain why a supplier may decline a fixed blend. Lyophilised research peptides are typically stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light. Repeated freeze–thaw cycles should be avoided, and reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. A single blended vial may raise questions about homogeneity, compatibility and stability that the supplier cannot answer within its existing catalogue documentation. Refusal can therefore be a quality-control decision: the supplier may be unwilling to release a presentation it cannot characterise or support consistently.
Experimental design is another factor. A fixed ratio limits the laboratory’s ability to vary concentrations for an in-vitro assay, prepare controls, or investigate each component separately. Separate vials allow the laboratory to prepare diluent volumes and concentrations appropriate to the assay, while keeping the work inside an in-vitro workflow. The shop’s free peptide reconstitution calculator is described for laboratory research use only, including mg, mcg, mL and syringe-scale conversions; it must not be used for human or veterinary dosing. A supplier may refuse a fixed blend because the requested format invites handling assumptions that fall outside the shop’s research-use-only model.
For a first-time UK research order, the more reliable route is usually to request individual catalogue items, check the batch CoA before use, confirm the label reference and follow the laboratory’s COSHH and storage procedures. If an experimental design genuinely requires a combination, that should be prepared within the laboratory’s controlled workflow from individually documented materials, not assumed to be available as a custom blend. All materials remain not for human or veterinary use, and any combining, reconstitution or handling must stay within controlled in-vitro research and analytical work.
